Aging of hematopoietic stem cells: DNA damage and mutations?

Experimental Hematology

Volumn 44, Issue 10, 2016, Pages 895-901

  Moehrle, Bettina M ^a   Geiger, Hartmut ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; PROTEIN P53;

BONE MARROW DEPRESSION; CELL AGING; CELL CYCLE ARREST; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA END JOINING REPAIR; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTONE PHOSPHORYLATION; HOMOLOGOUS RECOMBINATION; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MUTATION RATE; MUTATIONAL LOAD; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE; AGING; ANIMAL; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTATION; OXIDATIVE STRESS;

AGING; ANIMALS; APOPTOSIS; CELL AGING; CELL CYCLE; CELL DIFFERENTIATION; DNA DAMAGE; EPIGENESIS, GENETIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MUTATION; OXIDATIVE STRESS;

EID: 84989821622     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2016.06.253     Document Type: Review

References (81)

1. 1 Ogawa, M., Differentiation and proliferation of hematopoietic stem cells. Blood 81 (1993), 2844–2853.
2. 2 Becker, A.J., McCulloch, E.A., Till, J.E., Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow Cells. Nature 197 (1963), 452–454.
3. 3 Siminovitch, L., McCulloch, E.A., Till, J.E., The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62 (1963), 327–336.
4. 4 Till, J.E., McCulloch, E.A., A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14 (1961), 213–222.
5. 5 Wu, A.M., Till, J.E., Siminovitch, L., McCulloch, E.A., Cytological evidence for a relationship between normal hematopoietic colony-forming cells and cells of the lymphoid system. J Exp Med 127 (1968), 455–464.
6. 6 Kiel, M.J., Yilmaz, O.H., Iwashita, T., Yilmaz, O.H., Terhorst, C., Morrison, S.J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005), 1109–1121.
7. 7 Yang, L., Bryder, D., Adolfsson, J., et al. Identification of Lin(–)Sca1(+)kit(+)CD34(+)Flt3– short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105 (2005), 2717–2723.
8. 8 Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., Mulligan, R.C., Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183 (1996), 1797–1806.
9. 9 Cheshier, S.H., Morrison, S.J., Liao, X., Weissman, I.L., In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 96 (1999), 3120–3125.
10. 10 Walter, D., Lier, A., Geiselhart, A., et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520 (2015), 549–552.
11. 11 Cheng, T., Rodrigues, N., Shen, H., et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287 (2000), 1804–1808.
12. 12 Wilson, A., Trumpp, A., Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6 (2006), 93–106.
13. 13 de Haan, G., Nijhof, W., Van Zant, G., Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: Correlation between lifespan and cycling activity. Blood 89 (1997), 1543–1550.
14. 14 Rossi, D.J., Bryder, D., Zahn, J.M., et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 102 (2005), 9194–9199.
15. 15 Chambers, S.M., Goodell, M.A., Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 3 (2007), 201–211.
16. 16 Morrison, S.J., Wandycz, A.M., Akashi, K., Globerson, A., Weissman, I.L., The aging of hematopoietic stem cells. Nat Med 2 (1996), 1011–1016.
17. 17 Sudo, K., Ema, H., Morita, Y., Nakauchi, H., Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 192 (2000), 1273–1280.
18. 18 Kamminga, L.M., van Os, R., Ausema, A., et al. Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging. Stem Cells 23 (2005), 82–92.
19. 19 Janzen, V., Forkert, R., Fleming, H.E., et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006), 421–426.
20. 20 Flach, J., Bakker, S.T., Mohrin, M., et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512 (2014), 198–202.
21. 21 Liang, Y., Van Zant, G., Szilvassy, S.J., Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106 (2005), 1479–1487.
22. 22 Köhler, A., Schmithorst, V., Filippi, M.D., et al. Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 114 (2009), 290–298.
23. 23 Chambers, S.M., Shaw, C.A., Gatza, C., Fisk, C.J., Donehower, L.A., Goodell, M.A., Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol, 5, 2007, e201.
24. 24 Geiger, H., Denkinger, M., Schirmbeck, R., Hematopoietic stem cell aging. Curr Opin Immunol 29 (2014), 86–92.
25. 25 McKerrell, T., Vassiliou, G.S., Aging as a driver of leukemogenesis. Sci Transl Med, 7, 2015, 306fs38.
26. 26 Genovese, G., Kähler, A.K., Handsaker, R.E., et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371 (2014), 2477–2487.
27. 27 Jaiswal, S., Fontanillas, P., Flannick, J., et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371 (2014), 2488–2498.
28. 28 McKerrell, T., Park, N., Moreno, T., et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep 10 (2015), 1239–1245.
29. 29 Florian, M.C., Dörr, K., Niebel, A., et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 10 (2012), 520–530.
30. 30 Beerman, I., Bock, C., Garrison, B.S., et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 12 (2013), 413–425.
31. 31 Pietras, E.M., Warr, M.R., Passegué, E., Cell cycle regulation in hematopoietic stem cells. J Cell Biol 195 (2011), 709–720.
32. 32 Rossi, D.J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., Weissman, I.L., Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447 (2007), 725–729.
33. 33 Geiger, H., de Haan, G., Florian, M.C., The ageing haematopoietic stem cell compartment. Nat Rev Immunol 13 (2013), 376–389.
34. 34 Ito, K., Hirao, A., Arai, F., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004), 997–1002.
35. 35 Navarro, S., Meza, N.W., Quintana-Bustamante, O., et al. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther 14 (2006), 525–535.
36. 36 Nijnik, A., Woodbine, L., Marchetti, C., et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447 (2007), 686–690.
37. 37 Parmar, K., Kim, J., Sykes, S.M., et al. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells 28 (2010), 1186–1195.
38. 38 Prasher, J.M., Lalai, A.S., Heijmans-Antonissen, C., et al. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc−/− mice. EMBO J 24 (2005), 861–871.
39. 39 Reese, J.S., Liu, L., Gerson, S.L., Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 102 (2003), 1626–1633.
40. 40 Ruzankina, Y., Pinzon-Guzman, C., Asare, A., et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1 (2007), 113–126.
41. 41 Zhang, Q.S., Marquez-Loza, L., Eaton, L., et al. Fancd2–/– mice have hematopoietic defects that can be partially corrected by resveratrol. Blood 116 (2010), 5140–5148.
42. 42 d'Adda di Fagagna, F., Living on a break: Cellular senescence as a DNA-damage response. Nat Rev Cancer 8 (2008), 512–522.
43. 43 Blanpain, C., Mohrin, M., Sotiropoulou, P.A., Passegué, E., DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8 (2011), 16–29.
44. 44 Bartek, J., Lukas, J., DNA Damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 19 (2007), 238–245.
45. 45 Inomata, K., Aoto, T., Binh, N.T., et al. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 137 (2009), 1088–1099.
46. 46 Wang, J., Sun, Q., Morita, Y., et al. A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 148 (2012), 1001–1014.
47. 47 Khanna, K.K., Jackson, S.P., DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 27 (2001), 247–254.
48. 48 Mohrin, M., Bourke, E., Alexander, D., et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7 (2010), 174–185.
49. 49 Insinga, A., Cicalese, A., Faretta, M., et al. DNA Damage in Stem Cells Activates p21, Inhibits p53, and Induces Symmetric Self-Renewing Divisions. Proc Natl Acad Sci U S A 110 (2013), 3931–3936.
50. 50 Beerman, I., Seita, J., Inlay, M.A., Weissman, I.L., Rossi, D.J., Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell 15 (2014), 37–50.
51. 51 Di Leonardo, A., Linke, S.P., Clarkin, K., Wahl, G.M., DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8 (1994), 2540–2551.
52. 52 Nakamura, A.J., Chiang, Y.J., Hathcock, K.S., et al. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin, 1, 2008, 6.
53. 53 Li, M., He, Y., Dubois, W., Wu, X., Shi, J., Huang, J., Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 46 (2012), 30–42.
54. 54 Lee, H.W., Blasco, M.A., Gottlieb, G.J., Horner, J.W. II, Greider, C.W., DePinho, R.A., Essential role of mouse telomerase in highly proliferative organs. Nature 392 (1998), 569–574.
55. 55 Barlow, C., Hirotsune, S., Paylor, R., et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86 (1996), 159–171.
56. 56 Ito, K., Hirao, A., Fumio Arai, F., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12 (2006), 446–451.
57. 57 Bender, C.F., Sikes, M.L., Sullivan, R., et al. Cancer predisposition and hematopoietic failure in Rad50S/S Mice. Genes Dev 16 (2002), 2237–2251.
58. 58 Kenyon, J., Gerson, S.L., The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res 35 (2007), 7557–7565.
59. 59 Dumble, M., Moore, L., Chambers, S.M., et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 109 (2007), 1736–1742.
60. 60 Rübe, C.E., Fricke, A., Widmann, T.A., et al. Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One, 6, 2011, e17487.
61. 61 Moehrle, B.M., Nattamai, K., Brown, A., et al. Stem cell-specific mechanisms ensure genomic fidelity within HSCs and upon aging of HSCs. Cell Rep 13 (2015), 2412–2424.
62. 62 Dempsey, J.L., Pfeiffer, M., Morley, A.A., Effect of dietary restriction on in vivo somatic mutation in mice. Mutat Res 291 (1993), 141–145.
63. 63 Vijg, J., Busuttil, R.A., Bahar, R., Dollé, M.E., Aging and genome maintenance. Ann N Y Acad Sci 1055 (2005), 35–47.
64. 64 Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368 (2013), 2059–2074.
65. 65 Welch, J.S., Ley, T.J., Link, D.C., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150 (2012), 264–278.
66. 66 Xie, M., Lu, C., Wang, J., et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20 (2014), 1472–1478.
67. 67 Papaemmanuil, E., Gerstung, M., Malcovati, L., et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122 (2013), 3616–3627 quiz 3699.
68. 68 Rozhok, A.I., Salstrom, J.L., DeGregori, J., Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia. Proc. Natl. Acad. Sci 113 (2016), 1050–1055.
69. 69 Geiger, H., Schleimer, D., Nattamai, K.J., Dannenmann, S.R., Davies, S.M., Weiss, B.D., Mutagenic potential of temozolomide in bone marrow cells in vivo. Blood 107 (2006), 3010–3011.
70. 70 Kushner, B.H., Laquaglia, M.P., Kim Kramer, K., Modak, S., Cheung, N.K., Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: Possible leukemogenic role of temozolomide. Pediatr Blood Cancer 51 (2008), 552–554.
71. 71 Noronha, V., Berliner, N., Ballen, K.K., et al. Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature. Neuro Oncol 8 (2006), 280–283.
72. 72 Su, Y.W., Chang, M.C., Chiang, M.F., Hsieh, R.K., Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neurooncol 71 (2005), 315–318.
73. 73 Krejci, O., Wunderlich, M., Geiger, H., et al. p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death. Blood 111 (2008), 2190–2199.
74. 74 Tomasetti, C., Vogelstein, B., Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347 (2015), 78–81.
75. 75 Vas, V., Senger, K., Dörr, K., Niebel, A., Geiger, H., Aging of the microenvironment influences clonality in hematopoiesis. PLoS One, 7, 2012, e42080.
76. 76 Vas, V., Wandhoff, C., Dorr, K., Niebel, A., Geiger, H., Contribution of an aged microenvironment to aging-associated myeloproliferative disease. PLoS One, 7, 2012, e31523.
77. 77 Rozhok, A.I., Salstrom, J.L., DeGregori, J., Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia. Proc Natl Acad Sci U S A 113 (2016), 1050–1055.
78. 78 Schuler, N., Rübe, C.E., Accumulation of DNA damage-induced chromatin alterations in tissue-specific stem cells: The driving force of aging?. PLoS One, 8, 2013, e63932.
79. 79 Armitage, P., Doll, R., The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8 (1954), 1–12.
80. 80 Nordling, C.O., A new theory on cancer-inducing mechanism. Br J Cancer 7 (1953), 68–72.
81. 81 Tothova, Z., Kollipara, R., Huntly, B.J., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128 (2007), 325–339.